Dx/Rx: Pancreatic Cancer

Pancreatic Cancer

AvMaeve Lowery,Eileen O'Reilly

Häftad, Engelska, 2010

Del i serien Jones & Bartlett Learning

379 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

Beskrivning

Dx/Rx: Pancreatic Cancer was recently honored with 4 Stars from Doody's Book Review!Written by two expert oncologists specializing in pancreatic cancer, Dx/Rx: Pancreatic Cancer is a concise pocket reference for all professional caregivers of patients with pancreatic cancer. This handy guide provides comprehensive, up-to-date information on the epidemiology, symptoms, diagnosis, and management of malignancies of the pancreas. Topics include detailed outline of the diagnosis process and staging, molecular pathogenesis, localized diseases and advanced cases, metastatic pancreatic cancer, uncommon pancreatic malignancies, and information on supportive care. Presented in a quick-reference format, Dx/Rx: Pancreatic Cancer is an essential guide for on the ward or in the clinic.

Produktinformation

Utgivningsdatum:2010-10-21
Mått:112 x 203 x 10 mm
Vikt:652 g
Format:Häftad
Språk:Engelska
Serie:Jones & Bartlett Learning
Antal sidor:122
Förlag:Jones and Bartlett Publishers, Inc
ISBN:9780763780654

Utforska kategorier

Onkologi inom Medicin

Mer om författaren

Dr. Eileen M. O’Reilly is an Associate Member of the in the GI Medical Oncology service at Memorial Sloan-Kettering Cancer Center (MSKCC) in New York and an Associate Professor of Medicine at Weill Medical College of Cornell University.'Dr. O’Reilly received her medical degree at Trinity College (Dublin University) in Ireland, where she was born.'She completed her residency training in Ireland and Fellowship training at MSKCC and has been a faculty member in the GI Oncology service at MSKCC since that time.'Dr. O’Reilly has pancreatic, biliary, neuroendocrine and primary liver cancers as the major focus of her clinical and research activities.'Research initiatives include integration of molecular-based therapies for the treatment of pancreas cancer along with development of adjvuant and neoadjuvant therapy.'At a national level, Dr. O’Reilly is a member of CALGB’s GI committee and also participates in RTOG and ACOSOG.'Dr. O’Reilly’s insitutional administrative commitments include participation in MSKCC’s IRB, Research Council and Clinical Council and Medical Board.'Dr. O’Reilly is also the current President of the MSKCC medical staff.